Bacterial meningitis: An update of new treatment options

  • Nau R
  • Djukic M
  • Spreer A
 et al. 
  • 27


    Mendeley users who have this article in their library.
  • 8


    Citations of this article.


The outcome of bacterial meningitis critically depends on the rapid initiation of bactericidal antibiotic therapy and adequate management of septic shock. In community-acquired meningitis, the choice of an optimum initial empirical antibiotic regimen depends on the regional resistance patterns. Pathogens resistant to antibacterials prevail in nosocomial bacterial meningitis. Dexamethasone is recommended as adjunctive therapy for community-acquired meningitis in developed countries. In comatose patients, aggressive measures to lower intracranial pressure

Author-supplied keywords

  • Ampicillin
  • Listeria monocytogenes
  • Neisseria meningitidis
  • Streptococcus pneumoniae
  • cefepime
  • ceftazidime
  • ceftriaxone
  • clindamycin
  • complement
  • daptomycin
  • eritoran
  • glycerol
  • hypothermia
  • immunotherapy
  • linezolid
  • monoclonal antibodies
  • n-acetylcysteine
  • palmitoylethanolamide
  • paracetamol
  • resveratrol
  • rifampicin
  • seliciclib
  • vancomycin

Get free article suggestions today

Mendeley saves you time finding and organizing research

Sign up here
Already have an account ?Sign in

Find this document

Get full text


  • Roland Nau

  • Marija Djukic

  • Annette Spreer

  • Sandra Ribes

  • Helmut Eiffert

Cite this document

Choose a citation style from the tabs below

Save time finding and organizing research with Mendeley

Sign up for free